Skip to content
healthcare.dev

Carbamazepine

NDC 68094-125, Carbamazepine, suspension, from Precision Dose, Inc..

Product NDC
68094-125
Status
Listed
Labeler
Precision Dose, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214277
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68094-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBAMAZEPINE100 mg/5mL

Pharmacologic classes

Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
68094-125-62680940125623 TRAY in 1 CASE (68094-125-62) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (68094-125-59)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/359585dc-ad0f-465b-b5c4-c4204bef0b0a

Use it

Look up 68094-125 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68094-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68094-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.